Drugs / Vedolizumab SC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03949621 | Feb → Jul 2018 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vedolizumab SC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03949621 ↗ |
| Route | Subcutaneous | “injection, subcutaneously using a PFS, once on Day 1.” NCT03949621 ↗ |